keyword
https://read.qxmd.com/read/38650114/a-spontaneous-hyperglycaemic-cynomolgus-monkey-presents-cognitive-deficits-neurological-dysfunction-and-cataract
#41
JOURNAL ARTICLE
Hongdi Huang, Jianglin Pu, Yufang Zhou, Yang Fan, Yali Zhang, Yanling Li, Yangzhuo Chen, Yun Wang, Xiaomei Yu, Bulgin Dmitry, Zhu Zhou, Jianhong Wang
Chronic hyperglycaemia is a chief feature of diabetes mellitus and complicates with many systematic anomalies. Non-human primates (NHPs) are excellent for studying hyperglycaemia or diabetes and associated comorbidities, but lack behavioural observation. In the study, behavioural, brain imaging and histological analysis were performed in a case of spontaneously hyperglycaemic (HGM) Macaca fascicularis. The results were shown that the HGM monkey had persistent body weight loss, long-term hyperglycaemia, insulin resistance, dyslipidemia, but normal concentrations of insulin, C-peptide, insulin autoantibody, islet cell antibody and glutamic acid decarboxylase antibody...
June 2024: Clinical and Experimental Pharmacology & Physiology
https://read.qxmd.com/read/38649395/external-evaluation-of-a-deep-learning-based-approach-for-automated-brain-volumetry-in-patients-with-huntington-s-disease
#42
JOURNAL ARTICLE
Robert Haase, Nils Christian Lehnen, Frederic Carsten Schmeel, Katerina Deike, Theodor Rüber, Alexander Radbruch, Daniel Paech
A crucial step in the clinical adaptation of an AI-based tool is an external, independent validation. The aim of this study was to investigate brain atrophy in patients with confirmed, progressed Huntington's disease using a certified software for automated volumetry and to compare the results with the manual measurement methods used in clinical practice as well as volume calculations of the caudate nuclei based on manual segmentations. Twenty-two patients were included retrospectively, consisting of eleven patients with Huntington's disease and caudate nucleus atrophy and an age- and sex-matched control group...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38646608/distinct-eye-movement-patterns-to-complex-scenes-in-alzheimer-s-disease-and-lewy-body-disease
#43
JOURNAL ARTICLE
Yasunori Yamada, Kaoru Shinkawa, Masatomo Kobayashi, Miyuki Nemoto, Miho Ota, Kiyotaka Nemoto, Tetsuaki Arai
BACKGROUND: Alzheimer's disease (AD) and Lewy body disease (LBD), the two most common causes of neurodegenerative dementia with similar clinical manifestations, both show impaired visual attention and altered eye movements. However, prior studies have used structured tasks or restricted stimuli, limiting the insights into how eye movements alter and differ between AD and LBD in daily life. OBJECTIVE: We aimed to comprehensively characterize eye movements of AD and LBD patients on naturalistic complex scenes with broad categories of objects, which would provide a context closer to real-world free viewing, and to identify disease-specific patterns of altered eye movements...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38646321/chronic-visual-abnormality-in-an-elderly-patient-with-temporal-lobe-epilepsy
#44
Kiyohiro Atsuji, Shuichiro Neshige, Narumi Ohno, Hirofumi Maruyama
A 79-year-old woman visited our department for chronic visual field abnormalities with a floating sensation for two months. Neurological and ophthalmologic examinations yielded normal results, except for brain MRI indicating left hippocampal atrophy. Cognitive function tests were normal. EEG revealed frequent spikes and slow waves in the left frontotemporal region, corroborated by reduced accumulation in 123 I-iomazenil single photon emission computed tomography. A diagnosis of temporal lobe epilepsy was established, and treatment with lacosamide resulted in a remarkable improvement in symptoms and EEG findings...
March 2024: Curēus
https://read.qxmd.com/read/38645663/precise-prediction-of-cerebrospinal-fluid-amyloid-beta-protein-for-early-alzheimer-s-disease-detection-using-multimodal-data
#45
JOURNAL ARTICLE
Jingnan Sun, Zengmai Xie, Yike Sun, Anruo Shen, Renren Li, Xiao Yuan, Bai Lu, Yunxia Li
Alzheimer's disease (AD) constitutes a neurodegenerative disorder marked by a progressive decline in cognitive function and memory capacity. The accurate diagnosis of this condition predominantly relies on cerebrospinal fluid (CSF) markers, notwithstanding the associated burdens of pain and substantial financial costs endured by patients. This study encompasses subjects exhibiting varying degrees of cognitive impairment, encompassing individuals with subjective cognitive decline, mild cognitive impairment, and dementia, constituting a total sample size of 82 participants...
May 2024: MedComm
https://read.qxmd.com/read/38645488/hippocampal-subfield-volumetric-changes-after-radiotherapy-for-brain-metastases
#46
JOURNAL ARTICLE
Klara Holikova, Iveta Selingerova, Petr Pospisil, Martin Bulik, Ludmila Hynkova, Ivana Kolouskova, Lucie Hnidakova, Petr Burkon, Marek Slavik, Jiri Sana, Tomas Holecek, Jiri Vanicek, Pavel Slampa, Radim Jancalek, Tomas Kazda
BACKGROUND: Changes in the hippocampus after brain metastases radiotherapy can significantly impact neurocognitive functions. Numerous studies document hippocampal atrophy correlating with the radiation dose. This study aims to elucidate volumetric changes in patients undergoing whole-brain radiotherapy (WBRT) or targeted stereotactic radiotherapy (SRT) and to explore volumetric changes in the individual subregions of the hippocampus. METHOD: Ten patients indicated to WBRT and 18 to SRT underwent brain magnetic resonance before radiotherapy and after 4 months...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38645255/impaired-language-in-alzheimer-s-disease-a-comparison-between-english-and-persian-implicates-content-word-frequency-rather-than-the-noun-verb-distinction
#47
Mahya Sanati, Sabereh Bayat, Mehrdad Mohammad Panahi, Amirhossein Khodadadi, Sahar Rezaee, Mahdieh Ghasimi, Sara Besharat, Zahra Mahboubi Fooladi, Mostafa Almasi Dooghaee, Morteza Sanei Taheri, Bradford C Dickerson, Adele Goldberg, Neguine Rezaii
This study challenges the conventional psycholinguistic view that the distinction between nouns and verbs is pivotal in understanding language impairments in neurological disorders. Traditional views link frontal brain region damage with verb processing deficits and posterior temporoparietal damage with noun difficulties. However, this perspective is contested by findings from patients with Alzheimer's disease (pwAD), who show impairments in both word classes despite their typical temporoparietal atrophy. Notably, pwAD tend to use semantically lighter verbs in their speech than healthy individuals...
April 10, 2024: medRxiv
https://read.qxmd.com/read/38645137/alpha-synuclein-aggregates-are-phosphatase-resistant
#48
S G Choi, T Tittle, D Garcia-Prada, J H Kordower, R Melki, B A Killinger
UNLABELLED: Alpha-synuclein (αsyn) is an intrinsically disordered protein that aggregates in the brain in several neurodegenerative diseases collectively called synucleinopathies. Phosphorylation of αsyn at serine 129 (PSER129) was considered rare in the healthy human brain but is enriched in pathological αsyn aggregates and is used as a specific marker for disease inclusions. However, recent observations challenge this assumption by demonstrating that PSER129 results from neuronal activity and can be readily detected in the non-diseased mammalian brain...
April 9, 2024: bioRxiv
https://read.qxmd.com/read/38644883/causal-association-and-mediating-effect-of-blood-biochemical-metabolic-traits-and-brain-image-derived-endophenotypes-on-alzheimer-s-disease
#49
JOURNAL ARTICLE
Kang-Fu Yin, Xiao-Jing Gu, Wei-Ming Su, Ting Chen, Jiang Long, Li Gong, Zhi-Ye Ying, Meng Dou, Zheng Jiang, Qing-Qing Duan, Bei Cao, Xia Gao, Li-Yi Chi, Yong-Ping Chen
BACKGROUND: Recent genetic evidence supports that circulating biochemical and metabolic traits (BMTs) play a causal role in Alzheimer's disease (AD), which might be mediated by changes in brain structure. Here, we leveraged publicly available genome-wide association study data to investigate the intrinsic causal relationship between blood BMTs, brain image-derived phenotypes (IDPs) and AD. METHODS: Utilizing the genetic variants associated with 760 blood BMTs and 172 brain IDPs as the exposure and the latest AD summary statistics as the outcome, we analyzed the causal relationship between blood BMTs and brain IDPs and AD by using a two-sample Mendelian randomization (MR) method...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38642314/selective-vulnerability-of-hippocampal-sub-regions-in-patients-with-subcortical-vascular-mild-cognitive-impairment
#50
JOURNAL ARTICLE
Jianxiang Chen, Jianjun Wang, Ke Duan, Xinbei Li, Zhongxian Pan, Jinhuan Zhang, Xiude Qin, Yuanming Hu, Hanqing Lyu
Early diagnosis of subcortical vascular mild cognitive impairment (svMCI) is clinically essential because it is the most reversible subtype of all cognitive impairments. Since structural alterations of hippocampal sub-regions have been well studied in neurodegenerative diseases with pathophysiological cognitive impairments, we were eager to determine whether there is a selective vulnerability of hippocampal sub-fields in patients with svMCI. Our study included 34 svMCI patients and 34 normal controls (NCs), with analysis of T1 images and Montreal Cognitive Assessment (MoCA) scores...
April 20, 2024: Brain Imaging and Behavior
https://read.qxmd.com/read/38641994/gm1-gangliosidosis-type-ii-results-of-a-10-year-prospective-study
#51
JOURNAL ARTICLE
Precilla D'Souza, Cristan Farmer, Jean M Johnston, Sangwoo T Han, David Adams, Adam L Hartman, Wadih Zein, Laryssa A Huryn, Beth Solomon, Kelly King, Christopher P Jordan, Jennifer Myles, Elena-Raluca Nicoli, Caroline E Rothermel, Yoliann Mojica Algarin, Reyna Huang, Rachel Quimby, Mosufa Zainab, Sarah Bowden, Anna Crowell, Ashura Buckley, Carmen Brewer, Debra S Regier, Brian P Brooks, Maria T Acosta, Eva H Baker, Gilbert Vézina, Audrey Thurm, Cynthia J Tifft
PURPOSE: GM1 gangliosidosis (GM1) a lysosomal disorder caused by pathogenic variants in GLB1, is characterized by relentless neurodegeneration. There are no approved treatments. METHODS: Forty-one individuals with type II (late-infantile and juvenile) GM1 participated in a single-site prospective observational study. RESULTS: Classification of 37 distinct variants using ACMG criteria resulted in the upgrade of six and the submission of four new variants...
April 16, 2024: Genetics in Medicine: Official Journal of the American College of Medical Genetics
https://read.qxmd.com/read/38641846/genetic-underpinnings-explored-opa1-deletion-and-complex-phenotypes-on-chromosome-3q29
#52
JOURNAL ARTICLE
Ethan Hung-Hsi Wang, Pei-Hsuan Lin, Pei-Liang Wu, Eugene Yu-Chuan Kang, Laura Liu, Lung-Kun Yeh, Kuan-Jen Chen, Meng-Chang Hsiao, Nan-Kai Wang
BACKGROUND: Copy number variations (CNVs) have emerged as significant contributors to the elusive genetic causality of inherited eye diseases. In this study, we describe a case with optic atrophy and a brain aneurysm, in which a de novo CNV 3q29 deletion was identified. CASE PRESENTATION: A 40-year-old female patient was referred to our department after undergoing aneurysm transcatheter arterial embolization for a brain aneurysm. She had no history of systemic diseases, except for unsatisfactory best-corrected visual acuity (BCVA) since elementary school...
April 19, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38641653/who-am-i-with-my-lewy-bodies-the-insula-as-a-core-region-of-the-self-concept-networks
#53
JOURNAL ARTICLE
Alice Tisserand, Frédéric Blanc, Mary Mondino, Candice Muller, Hélène Durand, Catherine Demuynck, Paulo Loureiro de Sousa, Alix Ravier, Léa Sanna, Anne Botzung, Nathalie Philippi
BACKGROUND: Dementia with Lewy bodies (DLB) is characterized by insular atrophy, which occurs at the early stage of the disease. Damage to the insula has been associated with disorders reflecting impairments of the most fundamental components of the self, such as anosognosia, which is a frequently reported symptom in patients with Lewy bodies (LB). The purpose of this study was to investigate modifications of the self-concept (SC), another component of the self, and to identify neuroanatomical correlates, in prodromal to mild DLB...
April 19, 2024: Alzheimer's Research & Therapy
https://read.qxmd.com/read/38641466/adolescent-onset-epilepsy-and-deterioration-associated-with-cad-deficiency-a-case-report
#54
Sebastián Silva, Mónica Rosas, Benjamín Guerra, Marión Muñoz, Atsushi Fujita, Masamune Sakamoto, Naomichi Matsumoto
INTRODUCTION: CAD (MIM*114010) encodes a large multifunctional protein with the enzymatic activity of the first three enzymes initiating and controlling the de novo pyrimidine biosynthesis pathway. Biallelic pathogenic variants in CAD cause the autosomal recessive developmental and epileptic encephalopathy 50 (MIM #616457) or CAD deficiency presenting with epilepsy, status epilepticus (SE), neurological deterioration and anemia with anisopoikilocytosis. Mortality is around 9% of patients, mainly related to the no use of its specific treatment with uridine...
April 18, 2024: Brain & Development
https://read.qxmd.com/read/38640772/atrial-fibrillation-and-preexisting-cognitive-impairment-in-ischemic-stroke-patients-dijon-stroke-registry
#55
JOURNAL ARTICLE
Thibaut Pommier, Gauthier Duloquin, Valentin Pinguet, Pierre-Olivier Comby, Charles Guenancia, Yannick Béjot
BACKGROUND: Atrial Fibrillation (AF) is a common cause of ischemic stroke (IS), and is associated with cognitive impairment in the general population. We aimed to compare the prevalence of preexisting cognitive impairment between IS patients with and without AF, and to assess whether prior brain damage could contribute to the observed differences. METHODS: Patients with acute IS were prospectively identified from the population-based Dijon Stroke Registry, France...
April 15, 2024: Archives of Gerontology and Geriatrics
https://read.qxmd.com/read/38640150/association-of-basal-forebrain-volume-with-amyloid-tau-and-cognition-in-alzheimer-s-disease
#56
JOURNAL ARTICLE
Han Soo Yoo, Han-Kyeol Kim, Jae-Hoon Lee, Joong-Hyun Chun, Hye Sun Lee, Michel J Grothe, Stefan Teipel, Enrica Cavedo, Andrea Vergallo, Harald Hampel, Young Hoon Ryu, Hanna Cho, Chul Hyoung Lyoo
BACKGROUND: Degeneration of cholinergic basal forebrain (BF) neurons characterizes Alzheimer's disease (AD). However, what role the BF plays in the dynamics of AD pathophysiology has not been investigated precisely. OBJECTIVE: To investigate the baseline and longitudinal roles of BF along with core neuropathologies in AD. METHODS: In this retrospective cohort study, we enrolled 113 subjects (38 amyloid [Aβ]-negative cognitively unimpaired, 6 Aβ-positive cognitively unimpaired, 39 with prodromal AD, and 30 with AD dementia) who performed brain MRI for BF volume and cortical thickness, 18F-florbetaben PET for Aβ, 18F-flortaucipir PET for tau, and detailed cognitive testing longitudinally...
April 16, 2024: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38638150/progressive-thalamic-nuclear-atrophy-in-blepharospasm-and-blepharospasm-oromandibular-dystonia
#57
JOURNAL ARTICLE
Jinping Xu, Yuhan Luo, Jiana Zhang, Linchang Zhong, Huiming Liu, Ai Weng, Zhengkun Yang, Yue Zhang, Zilin Ou, Zhicong Yan, Qinxiu Cheng, Xinxin Fan, Xiaodong Zhang, Weixi Zhang, Qingmao Hu, Dong Liang, Kangqiang Peng, Gang Liu
The thalamus is considered a key region in the neuromechanisms of blepharospasm. However, previous studies considered it as a single, homogeneous structure, disregarding potentially useful information about distinct thalamic nuclei. Herein, we aimed to examine (i) whether grey matter volume differs across thalamic subregions/nuclei in patients with blepharospasm and blepharospasm-oromandibular dystonia; (ii) causal relationships among abnormal thalamic nuclei; and (iii) whether these abnormal features can be used as neuroimaging biomarkers to distinguish patients with blepharospasm from blepharospasm-oromandibular dystonia and those with dystonia from healthy controls...
2024: Brain communications
https://read.qxmd.com/read/38636610/mir-30a-5p-mediates-ferroptosis-of-hippocampal-neurons-in-chronic-cerebral-hypoperfusion-induced-cognitive-dysfunction-by-modulating-the-sirt1-nrf2-pathway
#58
JOURNAL ARTICLE
Lihua Wang, Mingjie Li, Bing Liu, Ruihan Zheng, Xinyi Zhang, Shuoyi Yu
OBJECTIVE: Chronic cerebral hypoperfusion (CCH) is a common cause of brain dysfunction. As a microRNA (also known as miRNAs or miRs), miR-30a-5p participates in neuronal damage and relates to ferroptosis. We explored the in vivo and in vitro effects and functional mechanism of miR-30a-5p in CCH-triggered cognitive impairment through the silent information regulator 1 (SIRT1)/nuclear factor erythroid 2-related factor 2 (NRF2) pathway. METHODS: After 1 month of CCH modeling through bilateral common carotid artery stenosis, mice were injected with 2μL antagomir (also known as anti-miRNAs) miR-30a-5p, with cognitive function evaluated by Morris water maze and novel object recognition tests...
April 16, 2024: Brain Research Bulletin
https://read.qxmd.com/read/38634687/serum-gfap-levels-correlate-with-astrocyte-reactivity-post-mortem-brain-atrophy-and-neurofibrillary-tangles
#59
JOURNAL ARTICLE
Pascual Sánchez-Juan, Elizabeth Valeriano-Lorenzo, Alicia Ruiz-González, Ana Belén Pastor, Hector Rodrigo Lara, Francisco López-González, María Ascensión Zea-Sevilla, Meritxell Valentí, Belen Frades, Paloma Ruiz, Laura Saiz, Iván Burgueño-García, Miguel Calero, Teodoro Del Ser, Alberto Rábano
Glial fibrillary acidic protein (GFAP), a proxy of astrocyte reactivity, has been proposed as biomarker of Alzheimer's disease. However, there is limited information about the correlation between blood biomarkers and post-mortem neuropathology. In a single-centre prospective clinicopathological cohort of 139 dementia patients, for which the time-frame between GFAP level determination and neuropathological assessment was exceptionally short (on average 139 days), we analysed this biomarker, measured at three time points, in relation to proxies of disease progression such as cognitive decline and brain weight...
April 18, 2024: Brain
https://read.qxmd.com/read/38634641/clinical-case-report-of-intractable-paroxysmal-sympathetic-hyperactivity-in-tango2-deficiency-disorder
#60
Kaitlin Morrison, Hitoshi Koshiya, Robert Safier, Amanda Brown, Carol May, Jerry Vockley, Lina Ghaloul-Gonzalez
TANGO2 deficiency disorder (TDD) is a neurodegenerative disease characterized by a broad and variable spectrum of clinical manifestations, even among individuals sharing the same pathogenic variants. Here, we report a severely affected individual with TDD presenting with intractable paroxysmal sympathetic hyperactivity (PSH). While progressive brain atrophy has been observed in TDD, PSH has not been reported. Despite comprehensive workup for an acute trigger, no definite cause was identified, and pharmacological interventions were ineffective to treat PSH...
April 18, 2024: American Journal of Medical Genetics. Part A
keyword
keyword
107045
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.